1. Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
    Bart Spiesschaert et al, 2021, Cancers CrossRef

  2. Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma


    Peng Wang et al, 2020, OncoTargets and Therapy CrossRef
  3. Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
    Chae-Ok Yun et al, 2022, Frontiers in Immunology CrossRef
  4. Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
    Joanna Jazowiecka-Rakus et al, 2022, Cancers CrossRef
  5. Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV-neuT) in Mice with Transplanted Salivary Gland Carcinoma Cells
    Chiara Focaccetti et al, 2020, Nutrients CrossRef
  6. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
    Molly C. Holbrook et al, 2021, Cancers CrossRef
  7. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
    Maryum Nisar et al, 2022, Frontiers in Oncology CrossRef
  8. Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
    Matin Ghasemi et al, 2023, Frontiers in Immunology CrossRef
  9. Recent progress in combination therapy of oncolytic vaccinia virus
    Seyedeh Nasim Mirbahari et al, 2024, Frontiers in Immunology CrossRef